References
- De Vita VT, Jr, Hellman S, Jaffe ES. Hodgkin's disease. Cancer: principles & practice of oncology4th ed., VT De Vita, Jr, S Hellman, SA Rosenberg. Lippincott, Philadelphia 1993; 1819–1824
- Specht L, Lauritzen AF, Nordentoft AM, et al. Danish National Hodgkin Study group. Tumor cell concentration and tumor burden in relation to histopathologic subtype and other prognostic factors in early stage Hodgkin's disease. Cancer 1990; 65: 2594–2601
- Colby TV, Hoppe RT, Warnke RA. Hodgkin's disease: a clinicopathologic study of 659 cases. Cancer 1981; 49: 1848–1858
- Wyllie AH, Duvall E. Cell injury and death. Oxford textbook of pathology, JOD McGee, PG Isaacson, NA Wright. Oxford University Press, OxfordUK 1992; Vol. 1: 141–193
- Linch DC, Berliner N, O'Flynn K, et al. Hodgkin-cell leukemia of B cell origin. Lancet 1985; 1(8420)78–80
- Swerdlow SH. Biopsy interpretation of lymph nodes. Raven, New York 1992; 302
- Brousset P, Benharroch D, Krajewski S, et al. Frequent expression of the cell death-inducing gene Bax in Reed-Sternberg cells of Hodgkin's disease. Blood 1996; 87: 2470–2475
- Schulze-Osthoff K, Walczak H, Droge W, Krammer PH. Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol. 1994; 127: 15–20
- Schwartz LM, Smith SW, Jones ME, Osborne BA. Do all programmed cell deaths occur via apoptosis?. Proc Natl Acad Sci USA 1993; 90: 980–984
- Kokileva L. Multistep chromatin degradation in apoptosis. Int Arch Allergy Immunol. 1994; 105: 339–343
- Payne CM, Bernstein H, Bernstein C, Garewal H. Role of apoptosis in biology and pathology: resistance to apoptosis in colon carcinogenesis. Ultrastruct Pathol. 1995; 19: 221–248
- Catchpoole DR, Stewart BW. Formation of apoptotic bodies is associated with internucleosomal DNA fragmentation during drug-induced apoptosis. Exp Cell Res. 1995; 216: 169–177
- Payne CM, Grogan TM, Spier CM. Lymphomas of the mediastinum. Ultrastruct Pathol. 1991; 15: 439–474
- Harmon BV. An ultrastructural study of spontaneous cell death in a mouse mastocytoma with particular reference to dark cells. J Pathol. 1987; 153: 345–355
- Parsons DF, Marko M., Braun SJ, Wansor KJ. “Dark cells” in normal, hyperplastic and promoter-treated mouse epidermis studied by conventional and high voltage electron microscopy. J Invest Dermatol. 1983; 81: 62–67
- Cross JM. Hodgkin's disease: histological classification and diagnosis. J Pathol. 1969; 22: 165–182
- Tobin DJ, Fenton DA, Kendall MD. Cell degeneration in alopecia areata: an ultrastructural study. Am J Dermatopathol. 1991; 13: 248–256
- Honma T, Bang D, Lee S, Saito T. Ultrastructure of endothelial cell necrosis in classical erythema nodosum. Hum Pathol. 1993; 24: 384–390
- Glaso M, Hovig T. The influence of fixation on the morphology of mouse epidermis: a light and electron-microscopic study with special reference to “dark cells” and epidermal carcinogenesis. Virchows Arch B. 1987; 54: 73–88
- Lorenzen J, Alavaikko M, Hansmann ML. Apoptosis in Hodgkin's disease. Pathologe. 1995; 16: 208–216
- Staunton MJ, Gaffney EF. Tumor type is a determinant of susceptibility to apoptosis. Am J Clin Pathol. 1995; 103: 300–307
- Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993; 14: 131–136
- Mangan DF, Mergenhagen SE, Wahl SM. Apoptosis in human monocytes: possible role in chronic inflammatory disease. J Periodontol. 1993; 64: 461–466
- Chen M, Quintans J, Fucks Z, Thompson C, Kufe DW, Weichselbaum RR. Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor α and ceramide. Cancer Res. 1995; 55: 991–994
- Benharroch D, Prinsloo I, Apte RN, et al. Interleukin-1 and TNF-α in Reed-Sternberg cells of Hodgkin's disease. Eur Cytokine Netw. 1996; 7: 51–56